Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2022: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Nutrien Ltd.✕ NTR · #789 in the world | Yield10 Bioscience, Inc.✕ YTEN |
|---|---|---|
| Profile | ||
| Country | 🇨🇦 Canada | 🇺🇸 USA |
| Sector | Basic Materials | Basic Materials |
| Industry | Agriculture Related | Agriculture Related |
| Founded | 2018 | 1992 |
| Size | ||
| Market cap | ||
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Nutrien Ltd. | Yield10 Bioscience, Inc. |
|---|---|---|
| 2025 | $26.9 BSEC | — |
| 2024 | $26.0 BSEC | — |
| 2023 | $29.1 BSEC | — |
| 2022 | $37.9 BSEC | $0 MSEC |
| 2021 | $27.7 BSEC | $1 MSEC |
| 2020 | $20.9 BSEC | $1 MSEC |
| 2019 | $20.1 BSEC | $1 MSEC |
| 2018 | $19.6 BSEC | $1 MSEC |
| 2017 | — | $1 MSEC |
| 2016 | — | $1 MSEC |
| 2015 | — | $1 MSEC |
| 2014 | — | $3 MSEC |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $33.0 B |
| $3 M* |
| Revenue | $26.9 B | — |
|---|
| Net income | $2.3 B▲ best | $-14 M |
|---|
| Employees | 24,700 | — |
|---|
| Valuation | ||
|---|---|---|
| P/E ratio | 14.6× | — |
| Price to sales | 1.2× | — |
| Price to book | 1.3× | — |
| Free cash flow yield | 6.4% | — |
| Profitability | ||
|---|---|---|
| Gross margin | 31.1% | — |
| Operating margin | 13.9% | — |
| Net margin | 8.4% | — |
| Return on equity | 9.1% | — |
| Return on invested capital | 8.5% | — |
| Growth | ||
|---|---|---|
| Revenue growth | 3.5% | — |
| Revenue growth, 3 years a year | -10.8% | — |
| Earnings per share growth | 242.7% | — |
| Financial strength | ||
|---|---|---|
| Debt to equity | 0.4× | — |
| Net debt to EBITDA | 1.4× | — |
| Interest cover | 5.4× | — |
| Cash | ||
|---|---|---|
| Free cash flow margin | 7.9% | — |
| Shareholder returns | ||
|---|---|---|
| Dividend yield | 3.2% | — |
| Shareholder yield | 4.9% | — |
| Strength scores | ||
|---|---|---|
| Piotroski F-score | 8 of 9 | — |
| Altman Z-score zone | grey | — |
|---|
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.